Multisystem Inflammatory Syndrome in Children and Cardiac Involvement: A Quaternary Center Experience
- PMID: 38635912
- DOI: 10.1097/INF.0000000000004266
Multisystem Inflammatory Syndrome in Children and Cardiac Involvement: A Quaternary Center Experience
Abstract
We prospectively analyzed clinical and laboratory characteristics associated with cardiac involvement and severe presentation in multisystem inflammatory syndrome in children. Of 146 patients, 66 (45.2%) had cardiac dysfunction and 26 (17.8%) had coronary artery abnormalities. Lower serum albumin levels, absolute lymphocyte and platelet counts, and elevated ferritin, fibrinogen, d-dimer and interleukin-6 levels were associated with cardiac dysfunction. Possible treatment complications were identified.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- COVID Data Tracker: Centers for Disease Control and Prevention. 2023. Available at: https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance .
-
- Levin M. Childhood multisystem inflammatory syndrome - a new challenge in the pandemic. N Engl J Med. 2020;383:393–395.
-
- Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607–1608.
-
- Centers for Disease Control and Prevention. CDC COVID Data Tracker. Available at: https://covid.cdc.gov/covid-data-tracker/#cases2020 .
-
- Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692–694.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical